Health

Acticor Biotech

Acticor Biotech is a biopharmaceutical company developing an innovative "first-in-class" treatment for cardiovascular emergencies, with a primary focus on Acute Ischelic Stroke
Industry
BioTech
Year invested
2017
Status
IPO on Euronext (ALACT)
Active
Other investors
Go Capital, Newton Biocapital, Mirae, CMS
Location
France